Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) – Leede Financial reduced their FY2026 earnings per share (EPS) estimates for Quipt Home Medical in a note issued to investors on Tuesday, February 11th. Leede Financial analyst D. Loe now expects that the company will post earnings of ($0.13) per share for the year, down from their prior forecast of ($0.12). The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.
Quipt Home Medical (NASDAQ:QIPT – Get Free Report) last issued its earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.
Quipt Home Medical Stock Performance
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the company. SG Americas Securities LLC acquired a new stake in Quipt Home Medical in the third quarter valued at about $44,000. Atom Investors LP acquired a new stake in Quipt Home Medical in the third quarter valued at $51,000. XTX Topco Ltd purchased a new position in shares of Quipt Home Medical in the third quarter valued at $54,000. Wells Fargo & Company MN raised its stake in shares of Quipt Home Medical by 30.9% during the 4th quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock worth $73,000 after buying an additional 5,625 shares during the last quarter. Finally, TD Waterhouse Canada Inc. raised its stake in shares of Quipt Home Medical by 83.4% during the 4th quarter. TD Waterhouse Canada Inc. now owns 27,435 shares of the company’s stock worth $76,000 after buying an additional 12,479 shares during the last quarter. 42.85% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, VP Patrick Dennis Gamble acquired 17,000 shares of the firm’s stock in a transaction on Thursday, December 26th. The stock was bought at an average cost of $2.45 per share, with a total value of $41,650.00. Following the transaction, the vice president now owns 40,057 shares of the company’s stock, valued at $98,139.65. The trade was a 73.73 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 13.40% of the company’s stock.
About Quipt Home Medical
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
See Also
- Five stocks we like better than Quipt Home Medical
- CD Calculator: Certificate of Deposit Calculator
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
- 3 Dividend Kings To Consider
- Cisco Roars Back: Is the Tech Giant Reborn?
- 3 REITs to Buy and Hold for the Long Term
- Albemarle’s Earnings Are In—Is the Stock a Buy Now?
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.